A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
about
The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.CDK4/6 inhibition is more active against the glioblastoma proneural subtype.Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs.
P2860
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A three-microRNA signature ide ...... h different clinical outcomes.
@en
type
label
A three-microRNA signature ide ...... h different clinical outcomes.
@en
prefLabel
A three-microRNA signature ide ...... h different clinical outcomes.
@en
P2093
P2860
P50
P356
P1433
P1476
A three-microRNA signature ide ...... h different clinical outcomes.
@en
P2093
Alessandra Palma
Alessandro Giuliani
Giovanna Marziali
Maurizio Martini
Roberto Pallini
P2860
P304
P356
10.1002/1878-0261.12047
P50
P577
2017-03-01T00:00:00Z